223 related articles for article (PubMed ID: 36232484)
21. Ninjin'yoeito suppressed the onset of arthritis, pain, and muscle atrophy in rheumatoid arthritis model mice.
Suginohara T; Kawaguchi M; Michihara S; Fujita N; Han LK; Takahashi R
Front Pharmacol; 2022; 13():974380. PubMed ID: 36601050
[TBL] [Abstract][Full Text] [Related]
22. Case Report: Nutritional Examination of Weight Loss Treatment Using Kampo.
Matsui Y; Matsui I
Front Nutr; 2021; 8():551373. PubMed ID: 33585540
[TBL] [Abstract][Full Text] [Related]
23. Effect of Ninjin'yoeito on the Loss of Skeletal Muscle Function in Cancer-Bearing Mice.
Ohsawa M; Maruoka J; Inami C; Iwaki A; Murakami T; Ishikura KI
Front Pharmacol; 2018; 9():1400. PubMed ID: 30555329
[TBL] [Abstract][Full Text] [Related]
24. Impact of
Okada KI; Kawai M; Hirono S; Miyazawa M; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Shimokawa T; Yamaue H
Curr Ther Res Clin Exp; 2020; 93():100605. PubMed ID: 33014206
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of Ninjin'yoeito for Chronic Obstructive Pulmonary Disease Patients with Frailty.
Hirai K; Homma T; Matsunaga T; Akimoto K; Yamamoto S; Suganuma H; Kashima A; Sato H; Ebato T; Miyata Y; Ohta S; Inoue H; Kusumoto S; Suzuki S; Tanaka A; Sagara H
J Altern Complement Med; 2020 Aug; 26(8):750-757. PubMed ID: 32551796
[No Abstract] [Full Text] [Related]
26. Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Expression.
Miyamoto A; Asai K; Kadotani H; Maruyama N; Kubo H; Okamoto A; Sato K; Yamada K; Ijiri N; Watanabe T; Kawaguchi T
Int J Chron Obstruct Pulmon Dis; 2020; 15():3063-3077. PubMed ID: 33273811
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Effect of Ninjin'yoeito on Regional Brain Glucose Metabolism by
Zhao J; Imai R; Ukon N; Shimoyama S; Tan C; Maejima Y; Omiya Y; Takahashi K; Nan G; Zhao S; Ito H; Shimomura K
Front Nutr; 2021; 8():657663. PubMed ID: 34055854
[No Abstract] [Full Text] [Related]
28. Japanese Kampo medicine ninjin'yoeito synergistically enhances tumor vaccine effects mediated by CD8
Takaku S; Shimizu M; Takahashi H
Oncol Lett; 2017 May; 13(5):3471-3478. PubMed ID: 28529575
[TBL] [Abstract][Full Text] [Related]
29. Case Report: Efficacy of Ninjin'yoeito Treatment for Idiopathic Pulmonary Fibrosis.
Kushima H; Ishii H; Fujita M
Front Nutr; 2021; 8():548076. PubMed ID: 33996870
[TBL] [Abstract][Full Text] [Related]
30. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
[TBL] [Abstract][Full Text] [Related]
31. Frailty Improvement by Multicomponent Drug, Ninjin'Yoeito, in Mild Cognitive Impairment and Mild Alzheimer's Disease Patients: An Open-Label Exploratory Study (FRAMINGO).
Okahara K; Ohsawa M; Haruta-Tsukamoto A; Miyoshi R; Funahashi H; Fukutani Y; Makita S; Matsuo H; Ishida Y
J Alzheimers Dis Rep; 2023; 7(1):107-117. PubMed ID: 36891253
[TBL] [Abstract][Full Text] [Related]
32. National trends in the prescribing of Ninjin'yoeito, a Kampo medicine, for older adults from 2015 to 2020 in Japan.
Sasaki Y; Hamada S; Arai I; Sakata N
Geriatr Gerontol Int; 2023 May; 23(5):396-398. PubMed ID: 36967456
[No Abstract] [Full Text] [Related]
33. Relationship between the severity of pre-frailty and the degree of adaptation of Ninjin'yoeito (NYT) on pre-frailty.
Amitani H; Suzuki H; Kobayashi H; Murayama M; Uto NS; Kuroda E; Kobayashi Y; Kawabe M; Amitani M; Inui A; Marunaka Y
Front Aging; 2024; 5():1304217. PubMed ID: 38681234
[TBL] [Abstract][Full Text] [Related]
34. Evaluating the Practicality of Causal Inference From Non-randomized Observational Data in Small-Scale Clinical Settings: A Study on the Effects of Ninjin'yoeito.
Okui N
Cureus; 2024 Mar; 16(3):e55825. PubMed ID: 38463406
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of Ninjin'yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial.
Yagi T; Sawada K; Miyamoto M; Kinose Y; Nakagawa S; Takiuchi T; Kodama M; Kobayashi E; Hashimoto K; Mabuchi S; Tomimatsu T; Yoshino K; Kimura T
BMC Womens Health; 2022 Jun; 22(1):229. PubMed ID: 35701778
[TBL] [Abstract][Full Text] [Related]
36. Ninjin'yoeito, a herbal medicine, enhances glucose tolerance in mice.
Zhang L; Gopalasingam G; Herzog H
Neuropeptides; 2021 Aug; 88():102150. PubMed ID: 33895618
[TBL] [Abstract][Full Text] [Related]
37. Ninjin'yoeito modulates feeding and activity under negative energy balance conditions via the NPY system.
Zhang L; Clark T; Gopalasingam G; Neely GG; Herzog H
Neuropeptides; 2021 Jun; 87():102149. PubMed ID: 33882337
[TBL] [Abstract][Full Text] [Related]
38. Maintaining Weight and Nutritional Status with Ninjin'yoeito in Elderly Patients with Chronic Wasting Diseases.
Nakagawa Y; Kagohashi K; Shioya A; Kinoshita K; Tsuji H; Satoh H
Sultan Qaboos Univ Med J; 2022 May; 22(2):280-282. PubMed ID: 35673286
[TBL] [Abstract][Full Text] [Related]
39. A Herbal Prescription of Insamyangyeongtang as a Therapeutic Agent for Frailty in Elderly: A Narrative Review.
Lee HG; Arai I; Kwon S
Nutrients; 2024 Mar; 16(5):. PubMed ID: 38474849
[TBL] [Abstract][Full Text] [Related]
40. Perspectives on the Use of Ninjin'yoeito in Modern Medicine: A Review of Randomized Controlled Trials.
Takayama S; Arita R; Ohsawa M; Kikuchi A; Yasui H; Makino T; Motoo Y; Ishii T
Evid Based Complement Alternat Med; 2019; 2019():9590260. PubMed ID: 31565066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
